General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

pane 4 content

Treatment

Treatment

Novartis has been in the front ranks of a change in the treatment of malaria – by launching a new generation of antimalarial medicines known as artemisinin-based combination therapies, or ACTs, and later the first dispersible ACT tailored to meet the needs of children, the most vulnerable to malaria.